Ignite Creation Date:
2024-05-06 @ 7:01 PM
Last Modification Date:
2024-10-26 @ 2:58 PM
Study NCT ID:
NCT05862545
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-21
First Post:
2023-05-08
Brief Title:
Outcomes in Real-life After Initation of Treatment With Trixeo Budesonide Glycopyrronium Formoterol
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-06-01
Start Date Type:
ACTUAL
Primary Completion Date:
2025-07-28
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-07-28
Completion Date Type:
ESTIMATED
First Submit Date:
2023-05-08
First Submit QC Date:
May 8 2023
Study First Post Date:
2023-05-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-17
Last Update Post Date:
2024-06-21
Last Update Post Date Type:
ACTUAL